Role of rosuvastatin and pitavastatin in alleviating diabetic cardiomyopathy in rats: Targeting of RISK, NF-κB/ NLRP3 inflammasome and TLR4/ NF-κB signaling cascades.
Diabetic cardiomyopathy (DCM) is a serious outcome of type II diabetes mellitus (T2DM) and a key contributor to high morbidity and death in diabetic individuals. The current research is intended to elucidate and compare the therapeutic benefits of rosuvastatin (RVS) and pitavastatin (PTS) in mitigat...
Saved in:
| Main Authors: | Dalia O Saleh, Nesma M E Abo El Nasr, Marawan A Elbaset, Marwa E Shabana, Tuba Esatbeyoglu, Sherif M Afifi, Ingy M Hashad |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0325767 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective role of remogliflozin against experimental liver fibrosis by activating AMPK/SIRT1/Nrf2 and suppressing NF-κB pathways
by: Naif ALSuhaymi, et al.
Published: (2025-06-01) -
Apoptotic cells induce NF-κB and inflammasome negative signaling.
by: Amir Grau, et al.
Published: (2015-01-01) -
SCFFbw7 Modulates the NFκB Signaling Pathway by Targeting NFκB2 for Ubiquitination and Destruction
by: Hidefumi Fukushima, et al.
Published: (2025-05-01) -
The role of NF-κB in diabetic cardiomyopathy
by: Huang-Jun Liu, et al.
Published: (2024-12-01) -
Regulation of pyroptosis by NF-κB signaling
by: Ling Yang, et al.
Published: (2025-01-01)